SON is an essential m(6)A target for hematopoietic stem cell fate Journal Article


Authors: Luo, H.; Cortés-López, M.; Tam, C. L.; Xiao, M.; Wakiro, I.; Chu, K. L.; Pierson, A.; Chan, M.; Chang, K.; Yang, X.; Fecko, D.; Han, G.; Ahn, E. Y. E.; Morris, Q. D.; Landau, D. A.; Kharas, M. G.
Article Title: SON is an essential m(6)A target for hematopoietic stem cell fate
Abstract: Stem cells regulate their self-renewal and differentiation fate outcomes through both symmetric and asymmetric divisions. m6A RNA methylation controls symmetric commitment and inflammation of hematopoietic stem cells (HSCs) through unknown mechanisms. Here, we demonstrate that the nuclear speckle protein SON is an essential m6A target required for murine HSC self-renewal, symmetric commitment, and inflammation control. Global profiling of m6A identified that m6A mRNA methylation of Son increases during HSC commitment. Upon m6A depletion, Son mRNA increases, but its protein is depleted. Reintroduction of SON rescues defects in HSC symmetric commitment divisions and engraftment. Conversely, Son deletion results in a loss of HSC fitness, while overexpression of SON improves mouse and human HSC engraftment potential by increasing quiescence. Mechanistically, we found that SON rescues MYC and suppresses the METTL3-HSC inflammatory gene expression program, including CCL5, through transcriptional regulation. Thus, our findings define a m6A-SON-CCL5 axis that controls inflammation and HSC fate. © 2023 Elsevier Inc.
Keywords: methylation; genetics; mouse; animal; metabolism; animals; mice; inflammation; cell fate; cell differentiation; methyltransferase; methyltransferases; messenger rna; rna, messenger; hematopoietic stem cells; stem cells; hematopoietic stem cell; differentiation; rna methylation; humans; human; rna binding proteins; rna modifications; nuclear speckles; son; mettl3 protein, human
Journal Title: Cell Stem Cell
Volume: 30
Issue: 12
ISSN: 1934-5909
Publisher: Cell Press  
Date Published: 2023-12-07
Start Page: 1658
End Page: 1673.e10
Language: English
DOI: 10.1016/j.stem.2023.11.006
PUBMED: 38065069
PROVIDER: scopus
PMCID: PMC10752439
DOI/URL:
Notes: Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PDF and PubMed -- MSK corresponding author is Michael Kharas -- MSK author Long Yat Tam's listed with the first name 'Cyrus' on the original publication -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Kharas
    96 Kharas
  2. Karen Chu
    9 Chu
  3. Hanzhi Luo
    22 Luo
  4. Quaid Morris
    36 Morris
  5. Xuejing Yang
    11 Yang
  6. Isaac Wakiro
    3 Wakiro
  7. Grace Yq Han
    6 Han
  8. Mandy Chan
    6 Chan
  9. Kathryn Chang
    6 Chang
  10. Michael Xiao
    4 Xiao
  11. Daniel Patrick Fecko
    1 Fecko
  12. Long Yat Tam
    3 Tam